Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P A Fasching

Showing results (51-60 of 109) with videos related to

Pageof 11
Sort By:
Geburtshilfe Und Frauenheilkunde|September 26, 2014
Risk Factors for Endometriosis in a German Case-Control StudyS Burghaus, P Klingsiek, P A Fasching, et al.
Geburtshilfe Und Frauenheilkunde|February 17, 2015
Biomarkers in Patients with Metastatic Breast Cancer and the PRAEGNANT Study NetworkP A Fasching, S Y Brucker, T N Fehm, et al.
Breast Cancer Research and Treatment|February 9, 2017
Safety and immunogenicity of neoadjuvant treatment using WT1-immunotherapeutic in combination with standard therapy in patients with WT1-positive Stage II/III breast cancer: a randomized Phase I studyM Higgins, G Curigliano, V Dieras, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 18, 2024
Event-free survival by residual cancer burden with pembrolizumab in early-stage TNBC: exploratory analysis from KEYNOTE-522L Pusztai, C Denkert, J O'Shaughnessy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 12, 2022
Neoadjuvant durvalumab improves survival in early triple-negative breast cancer independent of pathological complete responseS Loibl, A Schneeweiss, J Huober, et al.
ESMO Open|November 10, 2022
A multicentre, randomised, double-blind, phase II study to evaluate the tolerability of an induction dose escalation of everolimus in patients with metastatic breast cancer (DESIREE)M Schmidt, K Lübbe, T Decker, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 29, 2011
Accuracy of radiological tumour size assessment and the risk for re-excision in a cohort of primary breast cancer patientsM Meier-Meitinger, C Rauh, B Adamietz, et al.
European Journal of Cancer (Oxford, England : 1990)|October 26, 2018
Quality of life with talazoparib after platinum or multiple cytotoxic non-platinum regimens in patients with advanced breast cancer and germline BRCA1/2 mutations: patient-reported outcomes from the ABRAZO phase 2 trialS A Hurvitz, R G W Quek, N C Turner, et al.
European Journal of Cancer (Oxford, England : 1990)|August 13, 2018
Treatment and outcomes of patients in the Brain Metastases in Breast Cancer Network RegistryI Witzel, E Laakmann, R Weide, et al.
Geburtshilfe Und Frauenheilkunde|February 17, 2015
Comparison of Sonography versus Digital Breast Tomosynthesis to Locate Intramammary Marker ClipsR Schulz-Wendtland, P Dankerl, G Dilbat, et al.
Pageof 11

Showing results (51-60 of 109) with videos related to

Sort By:
Pageof 11
Geburtshilfe Und Frauenheilkunde|September 26, 2014
Risk Factors for Endometriosis in a German Case-Control StudyS Burghaus, P Klingsiek, P A Fasching, et al.
Geburtshilfe Und Frauenheilkunde|February 17, 2015
Biomarkers in Patients with Metastatic Breast Cancer and the PRAEGNANT Study NetworkP A Fasching, S Y Brucker, T N Fehm, et al.
Breast Cancer Research and Treatment|February 9, 2017
Safety and immunogenicity of neoadjuvant treatment using WT1-immunotherapeutic in combination with standard therapy in patients with WT1-positive Stage II/III breast cancer: a randomized Phase I studyM Higgins, G Curigliano, V Dieras, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 18, 2024
Event-free survival by residual cancer burden with pembrolizumab in early-stage TNBC: exploratory analysis from KEYNOTE-522L Pusztai, C Denkert, J O'Shaughnessy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 12, 2022
Neoadjuvant durvalumab improves survival in early triple-negative breast cancer independent of pathological complete responseS Loibl, A Schneeweiss, J Huober, et al.
ESMO Open|November 10, 2022
A multicentre, randomised, double-blind, phase II study to evaluate the tolerability of an induction dose escalation of everolimus in patients with metastatic breast cancer (DESIREE)M Schmidt, K Lübbe, T Decker, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 29, 2011
Accuracy of radiological tumour size assessment and the risk for re-excision in a cohort of primary breast cancer patientsM Meier-Meitinger, C Rauh, B Adamietz, et al.
European Journal of Cancer (Oxford, England : 1990)|October 26, 2018
Quality of life with talazoparib after platinum or multiple cytotoxic non-platinum regimens in patients with advanced breast cancer and germline BRCA1/2 mutations: patient-reported outcomes from the ABRAZO phase 2 trialS A Hurvitz, R G W Quek, N C Turner, et al.
European Journal of Cancer (Oxford, England : 1990)|August 13, 2018
Treatment and outcomes of patients in the Brain Metastases in Breast Cancer Network RegistryI Witzel, E Laakmann, R Weide, et al.
Geburtshilfe Und Frauenheilkunde|February 17, 2015
Comparison of Sonography versus Digital Breast Tomosynthesis to Locate Intramammary Marker ClipsR Schulz-Wendtland, P Dankerl, G Dilbat, et al.
Pageof 11